Researchers are increasingly interested in what GLP-1 drugs might be doing elsewhere in the body. Now a large new study suggests semaglutide may be associated with lower rates of several neurological and psychiatric problems—and researchers found evidence that weight loss alone doesn't explain the difference.
Researchers are increasingly interested in what GLP-1 drugs might be doing elsewhere in the body.
Now a large new study suggests semaglutide may be associated with lower rates of several neurological and psychiatric problems—and researchers found evidence that weight loss alone doesn't explain the...
Compared with matched metformin users, for example, dementia or […]
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Researchers are increasingly interested in what GLP-1 drugs might be doing elsewhere in the body. Now a large new study suggests semaglutide may be associated with lower rates of several neurological and psychiatric problems—and researchers found evidence that weight loss alone doesn't explain the difference. It's also far too early to start thinking of Ozempic or Wegovy as brain drugs.
Semaglutide has become famous for what it does to the waistline.
Open the app view to save this story, compare related coverage, and continue from the same source.